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Each year in the United States, approximately 6,000 cases of rabies are documented in animals, primar-
ily in the major wildlife reservoir species (ie, raccoons, 
bats, skunks, and foxes). These confirmed cases are 
invariably associated with 1 or more human and ani-
mal exposures to rabies. In addition, many domestic 
animals come into contact with sick wildlife or other 
animals that cannot be captured for rabies diagnostic 
testing and, depending on the geographic location and 
species of animal involved, may be considered poten-
tially exposed to rabies. As a result, thousands of dogs 
and cats are known to be exposed or are potentially ex-
posed to rabies each year in the United States. 
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Objective—To compare anamnestic antibody responses of dogs and cats with current ver-
sus out-of-date vaccination status.
Design—Cross-sectional study.
Animals—74 dogs and 33 cats.
Procedures—Serum samples were obtained from dogs and cats that had been exposed 
to rabies and brought to a veterinarian for proactive serologic monitoring or that had been 
brought to a veterinarian for booster rabies vaccination. Blood samples were collected on 
the day of initial evaluation (day 0) and then again 5 to 15 days later. On day 0, a rabies vac-
cine was administered according to label recommendations. Paired serum samples were 
analyzed for antirabies antibodies by means of a rapid fluorescent focus inhibition test.
Results—All animals had an antirabies antibody titer ≥ 0.5 IU/mL 5 to 15 days after booster 
vaccination. Dogs with an out-of-date vaccination status had a higher median increase in 
titer, higher median fold increase in titer, and higher median titer following booster vaccina-
tion, compared with dogs with current vaccination status. Most (26/33) cats, regardless 
of rabies vaccination status, had a titer ≥ 12 IU/mL 5 to 15 days after booster vaccination. 
Conclusions and Clinical Relevance—Results indicated that dogs with out-of-date vacci-
nation status were not inferior in their antibody response following booster rabies vaccina-
tion, compared with dogs with current vaccination status. Findings supported immediate 
booster vaccination followed by observation for 45 days of dogs and cats with an out-of-
date vaccination status that are exposed to rabies, as is the current practice for dogs and 
cats with current vaccination status. (J Am Vet Med Assoc 2015;246:205–211)
Regulations have been developed to minimize the 
public health risks that dogs and cats exposed or poten-
tially exposed to rabies and potentially incubating the 
virus may pose. These regulations vary, depending on 
locality, but most public health officials refer to or rely 
on the Compendium of Animal Rabies Prevention and 
Control1 for guidance in these situations. 
According to the current version of the compen-
dium, dogs and cats with current rabies vaccination 
status that have been exposed to an animal confirmed 
or suspected to be rabid should immediately receive a 
rabies booster vaccination and be observed for 45 days, 
most often, as allowed by jurisdictional authorities, 
under the owner’s supervision with no contact restric-
tions. The recommendation for dogs and cats that have 
never been vaccinated against rabies and that have been 
exposed to a rabid animal is euthanasia or quarantine 
for 6 months in a specialized facility. 
In contrast, the compendium guidelines are less 
clear when it comes to recommendations for dogs and 
cats overdue for a booster vaccination (ie, dogs and cats 
with out-of-date rabies vaccination status), suggesting 
that these animals be evaluated on a case-by-case ba-
sis that takes into account the severity of the exposure, 
time since the last rabies vaccination, number of rabies 
vaccinations received previously, current health status 
of the animal, and local rabies epidemiology.1 Unfortu-
nately, this recommendation for a case-by-case risk as-
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sessment coupled with concerns for public safety, a fear 
of liability, and the lack of published clinical data re-
garding response to rabies vaccination in dogs and cats 
with an out-of-date rabies vaccination status commonly 
leads to conservative handling of these animals. Most 
often, this means that public health officials consider 
these animals to be unvaccinated, resulting in either eu-
thanasia or a 6-month quarantine. 
The present study was designed to provide greater 
insight into the appropriate handling of dogs and cats 
with out-of-date rabies vaccination status that have 
been exposed to rabid animals. Specifically, the purpose 
of the study reported here was to compare anamnestic 
antibody responses of dogs and cats with current versus 
out-of-date rabies vaccination status. 
Materials and Methods
Sample acquisition—The first phase of the study 
involved serum samples from 10 dogs and 2 cats, from 
8 states, that had been exposed to rabies and for which 
the attending veterinarian or owner had contacted the 
Rabies Diagnostic Laboratory at Kansas State Univer-
sity between March 2010 and June 2012 for help in as-
sessing the immune state of the animal. The remainder 
of the study involved serum samples from an additional 
64 dogs and 31 cats that had been exposed to rabies and 
brought to a veterinarian for proactive serologic moni-
toring or that had not been exposed to rabies and had 
been brought to a veterinarian for booster rabies vac-
cination. In total, serum samples from 74 dogs and 33 
cats from 13 states collected over a period of 3.75 years 
were included. The study protocol was approved by the 
Kansas State University Institutional Animal Care and 
Use Committee (protocol No. 3193).
For each animal included in the study, a 2-mL se-
rum sample was obtained at the time of initial evalua-
tion (day 0) and then again 5 to 15 days later. On day 
0, a rabies vaccine of the attending veterinarian’s choice 
was administered to the animal according to label rec-
ommendations. Serum samples were shipped fresh 
to the Rabies Diagnostic Laboratory and analyzed for 
antirabies antibody titer by means of a rapid fluorescent 
focus inhibition test. 
Classification of rabies vaccination status—All 
dogs and cats included in the study were classified as 
having a current or out-of-date rabies vaccination sta-
tus. Rabies vaccination status was classified as current 
if the animal had received initial rabies vaccination and 
the initial (ie, day 0) serum sample was obtained < 1 
year after the initial vaccination or if the animal had 
received both an initial rabies vaccination and a rabies 
booster vaccination and the initial (day 0) serum sam-
ple was obtained < 3 years after the last vaccination. 
Otherwise, rabies vaccination status was classified as 
out of date.
A cutoff of 3 years since the last vaccination was 
used regardless of whether the last vaccine adminis-
tered had been licensed for a 1-year or 3-year dura-
tion, because the antigenic mass, carrier, adjuvant, and 
other characteristics of 1-year and 3-year vaccines from 
2 companies2,a were reportedly identical. One animal 
that received a 1-year vaccine was excluded from the 
data analysis because the companyb that manufactured 
the vaccine would neither confirm nor deny that their 
1-year and 3-year formulations were identical. 
Rapid fluorescent focus inhibition test—The rap-
id fluorescent focus inhibition test,3 a serum neutral-
ization test, was used to determine the titer of rabies 
neutralizing antibodies in all serum samples. Briefly, 
rabies virus was mixed with serial dilutions of each se-
rum sample, and the resulting mixture was incubated 
at 37°C for 90 minutes. Baby hamster kidney cells sus-
pended in Eagle minimum essential medium with 10% 
fetal bovine serum were then added, and the mixture 
was incubated for 20 to 24 hours at 37°C. Following 
fixation with 80% acetone, a conjugate of antirabies 
antibody labeled with fluorescein isothiocyanate was 
added to the cells. After washing, cells were counted by 
means of fluorescent microscopy to determine the ratio 
of infected to noninfected cells at each dilution. Results 
were compared with results for a standard control sam-
ple containing a known neutralizing antibody concen-
tration to determine the titer for each test sample.
End point dilution was not used to determine the 
specific antibody titer for samples that resulted in com-
plete neutralization of the virus at the highest serum 
dilution used. However, the maximum possible titer 
varied between test runs depending on the control sam-
ple’s ability to neutralize the challenge virus. Standard 
operating procedures for the test method defined a pri-
ori an acceptable range of titers for the control sample, 
with testing repeated if the titer for the control sample 
was outside the acceptable range. Because the lowest ti-
ter for control samples used in the present study was 12 
IU/mL, for calculation purposes, we reported results for 
test samples > 12 IU/mL as 12 IU/mL. In the statistical 
analysis, all titers reported as ≥ 12 IU/mL were treated 
as right censored. For comparison, a rabies neutralizing 
antibody titer ≥ 0.5 IU/mL is considered by the World 
Health Organization to be an adequate vaccine response 
for dogs and cats traveling to rabies-free areas.4
Data analysis—Rabies neutralizing antibody titers 
following booster vaccination (ie, days 5 to 15) were 
compared between dogs with current versus out-of-
date vaccination statuses by modeling the proportions 
of animals with titers exceeding various given values 
(sometimes referred to as a reverse cumulative distri-
bution). This approach was selected to account for the 
right censoring of titers for some animals. A propor-
tional hazards modelc was used to compare distribu-
tions of titers between the 2 groups (current vaccina-
tion status versus out-of-date vaccination status), with 
current vaccination status as the reference. In essence, 
the proportional hazards ratio represented the com-
parative ability of the 2 groups to reach a particular ti-
ter after booster vaccination on day 0. If the ratio was 
equal to 1, the 2 groups were considered identical. If 
the ratio was > 1, then the response to booster vaccina-
tion in animals with an out-of-date vaccination status 
was considered to be not as robust as the response in 
animals with a current vaccination status. Conversely, 
if the ratio was < 1, the response to booster vaccination 
in animals with an out-of-date vaccination status was 
considered superior to the response in animals with a 









current vaccination status. For purposes of the present 
study, we assumed the response to booster vaccination 
in animals with an out-of-date vaccination status was 
not clinically worse than the response in animals with 
a current vaccination status if the hazard ratio was < 
1.25. On the basis of an analysis of data from Mansfield 
et al,5 this choice of noninferiority margin was deter-
mined to be conservative. Formally, in the hypothesis 
test of noninferiority, the null hypothesis was that the 
ratio was ≥ 1.25 (ie, out-of-date vaccination status was 
inferior to current vaccination status), and the alterna-
tive hypothesis was that the ratio was < 1.25 (ie, out-of-
date vaccination status was noninferior to current vac-
cination status). Diagnostic graphs indicated the pro-
portional hazard model was appropriate for these data.
Results
Rabies neutralizing antibody titers for the 10 dogs 
and 2 cats in the first phase of the study were sum-
marized (Table 1). For all 12 animals, antibody titers 
5 to 15 days after booster vaccination were > 0.5 IU/
     Rabies  Titer after
  > 1 vaccine Label duration of Time since last vaccination Baseline  booster
Species  Exposure description  dose previously last vaccine (y) vaccination (mo) status titer (IU/mL) vaccination (IU/mL)
Dog* Contact with skunk Yes 3 39.0 OOD      9.7 12
Dog Exposed to rabid skunk Yes UK   9.0 C   0 12
Dog* Raccoon bite Yes 3 41.4 OOD 12 12
Dog* Raccoon bite Yes 1 18.1 C      0.7      3.4
Dog* Exposed to rabid skunk No 1 36.0 OOD      0.6 12
Dog Exposed to rabid skunk Yes 3 15.6 C 12 12
       
Dog* Exposed to rabid skunk No 1 15.6 OOD      0.2 12
Dog* Exposed to rabid skunk No 1 15.4 OOD      0.6 12
Dog* Raccoon bite Yes 1 30.5 C      1.8 12
Dog Exposed to rabid skunk Yes 3 10.7 C      3.1 12
Cat* Raccoon bite Yes 3 38.7 OOD      0.3 12
Cat* Exposed to bat Yes 3 44.9 OOD 12 12
*Quarantined for 6 months after rabies exposure; no animals developed signs of rabies-associated disease during quarantine, and all 12 
animals survived.
C = Current. OOD = Out of date. UK = Unknown. 
Rabies vaccination status was classified as current if the animal had received an initial rabies vaccination and the initial serum sample was 
obtained < 1 year after the initial vaccination or if the animal had received both an initial rabies vaccination and a rabies booster vaccination 1 
year later and the baseline serum sample was obtained < 3 years after the last vaccination. Otherwise, rabies vaccination status was classified 
as out of date. A cutoff of 3 years since the last vaccination was used regardless of whether the last vaccine administered had been licensed for 
a 1-year or 3-year duration, because formulations of the 1-year and 3-year vaccines were confirmed by the manufacturer to be identical.
Table 1—Rabies neutralizing antibody titers immediately prior to (baseline) and 5 to 15 days after booster vaccination in 10 dogs and 2 
cats that had been exposed to an animal confirmed or suspected to be rabid.
Species and Baseline titer Titer after booster Median
vaccination status  (IU/mL)* vaccination (IU/mL)* increase (IU/mL) Median fold rise
Dog    
  Current (n = 55) 2.6 (0–12) 11.1 (0.5–12) 3.1 0
  Out of date (n = 19) 2.0 (0–12) 12.0 (0.5–12) 8.1 2
Cat    
  Current (n = 7) 2.4 (0.1–12) 12.0 (2.6–12) 9.4 2
  Out of date (n = 26) 6.3 (0.3–12) 12.0 (2.9–12) 2.4 0
*Data are given as median (range). 
See Table 1 for remainder of key. 
Table 2—Rabies neutralizing antibody titers immediately before (baseline) and 5 to 15 days after booster 
vaccination in 74 dogs and 33 cats classified as having a current or out-of-date rabies vaccination status.
   Titer (IU/mL)   
Species and vaccination status 0.5 1.0 2.0 4.0 8.0 12.0
Dog      
  Current (n = 55) 55 (100) 53 (96) 50 (90) 40 (72) 34 (61) 26 (47)
  Out of date (n = 19) 19 (100) 18 (94) 18 (94) 16 (84) 13 (68) 13 (68)
Cat      
  Current (n = 7) 7 (100) 7 (100) 7 (100) 6 (85) 6 (85) 6 (85)
  Out of date (n = 26) 26 (100) 26 (100) 26 (100) 23 (88) 23 (88) 21 (80)
Data are given as number (%). 
See Table 1 for remainder of key.
Table 3—Number (percentage) of dogs and cats in Table 2 with rabies neutralizing antibody titers 5 
to 15 days after booster vaccination that equaled or exceeded various benchmarks above 0.5 IU/mL.










mL. Five of the animals were classified as having a cur-
rent vaccination status, and 7 were classified as having 
an out-of-date vaccination status. All 7 animals with an 
out-of-date vaccination status and 2 animals with a cur-
rent vaccination status were quarantined for 6 months, 
during which time no rabies-associated clinical disease 
was reported. All 12 animals survived following rabies 
exposure. The 2 animals with current vaccination sta-
tus that were quarantined had been exposed > 1 year 
(but < 3 years) after receiving a rabies vaccine labeled 
for 1-year duration. However, the manufacturer con-
firmed that the 1-year and 3-year formulations of this 
product were identical; therefore, for purposes of the 
present study, both animals were classified as having a 
current vaccination status.
Rabies neutralizing antibody titers before (day 0) 
and after (day 5 to 15) booster vaccination for all 74 
dogs and 33 cats included in the study were summa-
rized, along with median increase in titer and median 
fold increase (Table 2). Dogs with out-of-date vaccina-
tion status had a higher median increase in titer, higher 
median fold increase in titer, and higher median titer 
following booster vaccination, compared with dogs 
with current vaccination status. However, statistical 
analyses were not performed on these parameters. 
The percentages of dogs and cats in each vaccine cat-
egory with titers that equaled or exceeded various bench-
marks above 0.5 IU/mL were summarized (Table 3). All 
animals in the study had a titer ≥ 0.5 IU/mL 5 to 15 days 
after booster vaccination. This included the 14 dogs (9 
with current vaccination status and 5 with out-of-date 
vaccination status) and 2 cats (1 with current vaccination 
status and 1 with out-of-date vaccination status) that had 
titers < 0.5 IU/mL prior to booster vaccination (day 0; 
Table 4). Median increase in titer for dogs (Table 5) and 
cats (Table 6) with an out-of-date vaccination status was 
higher for those that had previously received only a single 
dose of vaccine, compared with those that had previously 
received ≥ 2 doses of vaccine. Again, however, no statisti-
cal analyses were performed on this parameter.
Reverse cumulative distributions of titers 5 to 15 
days after booster vaccination were calculated for dogs 
with current vaccination status and dogs with out-of-
date vaccination status (Figure 1). The hypothesis test 
for noninferiority was significant (P = 0.029), with out-
of-date dogs shown to be noninferior to current dogs, 
and the proportional hazards ratio (with current vac-
cination status as the reference) was 0.53 (95% confi-
dence interval, 0.20 to 1.12). Because the upper limit of 
the 95% confidence interval was < 1.25, the response to 
booster vaccination in dogs with an out-of-date vaccina-
tion status was considered to be noninferior to the re-
sponse in dogs with a current vaccination status.
Species and   Titer after
vaccination Baseline Time between booster
status titer (IU/mL) samples (d) vaccination (IU/mL)
Dog   
  Out of date 0.2 8 12
 0.2 7 12
 0 5 12
 0.4 7 2.4
 0 8 0.5
  Current 0 7 12
 0.4 7 4.4
 0.3 5 11.1
 0.4 7 0.5
 0.1 7 1.3
 0.1 7 6.1
 0 7 2
 0.1 5 4
 0.3 6 0.5
   
Cat   
  Out of date 0.3 5 12
  Current 0.1 6 12
Median titer after booster vaccination was 12 IU/mL for dogs 
with an out-of-date vaccination status and 4 IU/mL for dogs with a 
current vaccination status.
See Table 2 for key.
Table 4—Rabies neutralizing antibody titers immediately before 
(baseline) and 5 to 8 days after booster vaccination in 14 dogs 
and 2 cats with a titer < 0.5 IU/mL prior to booster vaccination.
No. of vaccine Baseline Time Titer after Time 
doses received titer between booster overdue for Increase in
previously  (IU/mL) samples (d) vaccination (IU/mL)  vaccination (mo) titer (IU/mL)
≥ 2 0.6 6 2.8 0.2 2.2
 0.4 7 2.4 0.3 2
 9.7 15 12 3 2.3
 4 7 5.9 4.8 1.9
 12 6 12 7.5 0
 3.9 7 12 10.6 8.1
 2.9 7 7.8 14.9 4.9
 0 8 0.5 19.7 0.5
 2 7 12 22.8 10
     
1 3.4 7 12 0.3 8.6
 0.6 10 12 3.4 11.4
 0.2 8 12 3.6 11.8
 0 5 12 5.9 12
 0.6 7 12 24 11.4
 0.2 7 12 36.1 11.8
Median increase in titer was 2.2 IU/mL for dogs that had previously received ≥ 2 doses of vaccine and was 
11.6 IU/mL for dogs that had previously received only a single dose of vaccine.
Table 5—Rabies neutralizing antibody titers immediately before (baseline) and 5 to 15 days after boost-
er vaccination for 15 dogs with an out-of-date vaccination status classified on the basis of number of 
rabies vaccinations received previously.









Because of the small number of cats in the study 
and the fact that most cats, regardless of whether they 
had a current (6/7) or out-of-date (21/26) vaccination 
status, had a titer ≥ 12 IU/mL 5 to 15 days after booster 
vaccination, proportional hazards analysis could not be 
used to analyze the response to booster vaccination in 
cats with current versus out-of-date vac-
cination status. 
Discussion
Results of the present study indi-
cated that the anamnestic responses of 
dogs and cats with an out-of-date rabies 
vaccination status were similar to the re-
sponses in animals with a current rabies 
vaccination status. Specifically, titers 5 to 
15 days after booster vaccination in dogs 
with an out-of-date vaccination status 
were shown to be noninferior to titers in 
dogs with a current vaccination status. 
Also, dogs with an out-of-date vaccina-
tion status had a higher median increase 
in titer, higher median fold increase in 
titer, and higher median titer follow-
ing booster vaccination, compared with 
dogs with current vaccination status; 
however, statistical analyses were not 
performed to compare these parameters 
between groups.
The noninferiority margin of 1.25 
used in the present study was selected 
because it has commonly been used in 
other studies as a conservative margin for hazard ra-
tio analyses. On the basis of an analysis of results re-
ported by Mansfield et al5 for dogs and cats vaccinated 
with 3 rabies vaccines, we determined that a margin of 
1.25 corresponded to a difference in titer between ani-
mals with an out-of-date vaccination status and naïve 
No. of vaccine Baseline Time Titer after Time
doses received titer between booster overdue for Increase
previously  (IU/mL) samples (d) vaccination (IU/mL) vaccination (mo) in titer (IU/mL)
≥ 2 12 8 12 0.1 0
 6.1 7 11.3 0.1 5.2
 12 8 12 0.1 0
 3.4 7 12 0.2 8.6
 12 7 12 0.2 0
 5.4 6 12 0.9 6.6
 6.4 7 9 1.1 2.6
 12 7 12 2.3 0
 12 7 12 2.5 0
 0.3 5 12 2.7 11.7
 3.4 7 3.7 2.9 0.3
 12 7 12 2.9 0
 8.9 7 12 3.2 3.1
 12 7 12 3.7 0
 12 7 12 5.6 0
 2.5 7 12 5.6 9.5
 2.4 7 12 8.4 9.6
 12 8 12 8.9 0
 2.4 6 12 15.9 9.6
 3 6 3.3 34.6 0.3
 0.6 7 2.9 46.1 2.3
     
1 0.6 5 12 4.9 11.4
 9.6 6 12 21.2 2.4
 2.7 6 12 38.5 9.3
Median increase in titer was 0.3 IU/mL for cats that had previously received ≥ 2 doses of vaccine and was 
9.3 IU/mL for cats that had previously received only a single dose of vaccine.
Table 6—Rabies neutralizing antibody titers immediately before (baseline) and 5 to 15 days after boost-
er vaccination for 24 cats with an out-of-date vaccination status classified on the basis of number of 
rabies vaccinations received previously.
Figure 1—Reverse cumulative distributions of rabies neutralizing antibody titers 5 to 15 days 
after booster vaccination in dogs with a current (n = 55; solid line) or out-of-date (19; dashed 
line) rabies vaccination status. The reverse cumulative proportion represents, for any given 
titer, the proportion of dogs with a titer equal to or greater than that titer. The hypothesis test 
for noninferiority was significant (P = 0.029), with out-of-date dogs shown to be noninferior 
to current dogs.










animals that was at least 88% of the difference in titer 
between animals with current vaccination status and 
naïve animals. Ng6 recommends that the noninferior-
ity margin preserve at least 80% of the advantage the 
active treatment holds over placebo. Therefore, we be-
lieve that the noninferiority margin of 1.25 used in the 
present study was conservative.
In the present study, we used 3 methods to com-
pare anamnestic responses to rabies vaccination in dogs 
and cats with current versus out-of-date vaccination 
status: fold rise in titer, absolute increase in titer, and 
absolute titer following booster vaccination. Evaluating 
the fold rise in titer gives an advantage to animals with 
a low starting titer. Therefore, because many animals 
in the present study with an out-of-date vaccination 
status had lower starting titers, we were not surprised 
that they had a higher fold rise in titer, compared with 
animals with a current vaccination status. 
Although absolute increase in titer following boost-
er vaccination provides some information on the anam-
nestic response to vaccination, it may not represent a 
true measure of protection. Assuming that neutralizing 
antibody titer is a measure of protection,7,8 then a rabies 
neutralizing antibody titer of 5.5 IU/mL should afford 
better protection than a titer of 0.5 IU/mL. However, 
when evaluating absolute increase in titer, an increase 
from 0.1 to 0.5 IU/mL is the same as an increase from 
5.1 to 5.5 IU/mL. 
In contrast to fold rise or absolute increase in titer, 
absolute titer following booster vaccination should pro-
vide a good indication of the level of protection achieved. 
In the present study, we found that the response for dogs 
with an out-of-date vaccination status was noninferior 
to the response for dogs with a current vaccination sta-
tus (P = 0.029). Unfortunately, we could not perform the 
same analyses for cats in the present study because of the 
low number of cats enrolled and the fact that most cats, 
regardless of whether they had a current or out-of-date 
vaccination status, achieved the maximum titer (≥ 12 IU/
mL) after booster vaccination. Given these high titers, 
even if a difference had been found between groups, it 
likely would not have been clinically meaningful.
Results of the present study may help clarify rec-
ommendations in the Compendium of Animal Rabies 
Prevention and Control1 for postexposure management 
of dogs and cats overdue for a booster vaccination that 
are exposed to an animal confirmed or suspected to be 
rabid. Currently, the guidelines recommend that such 
animals be evaluated on a case-by-case basis on the ba-
sis of the following 5 criteria: severity of the exposure, 
time since the last rabies vaccination, number of rabies 
vaccinations received previously, current health status 
of the animal, and local rabies epidemiology.
Importantly, the guidelines do not recommend 
altering postexposure management for dogs and cats 
with a current vaccination status on the basis of sever-
ity of the exposure. Considering that dogs and cats in 
the present study responded to rabies booster vaccina-
tion in a similar manner regardless of whether they had 
a current or out-of-date vaccination status, we believe 
that postexposure management should be the same for 
dogs and cats with current versus out-of-date vaccina-
tion status, regardless of the severity of exposure. 
With respect to time since the last rabies vaccina-
tion, we did not identify a difference in anamnestic 
response between animals with current versus out-of-
date vaccination status. In fact, dogs with an out-of-
date vaccination status generally had higher responses 
than did dogs with a current vaccination status.
Similarly, with respect to the number of rabies vac-
cinations received previously, we did not find a substan-
tial difference in anamnestic responses between dogs and 
cats that had previously received only a single dose of 
vaccine and those that had received ≥ 2 doses previously. 
However, age could have been a confounding factor, giv-
en that animals vaccinated only once had a median age of 
3 years, whereas animals vaccinated multiple times had 
a median age of 6 years, and immunosenescence in dogs 
and cats is well documented.9
We did not evaluate the effect of health status on 
anamnestic responses in the present study, and all ani-
mals were generally healthy. However, we recommend 
that, regardless of vaccination status, public health 
officers should be cautious when managing immuno-
compromised dogs and cats that have been exposed to 
rabid animals.
Finally, in suggesting that public health officials 
take local rabies epidemiology into consideration in the 
postexposure management of dogs and cats with an out-
of-date vaccination status that have been exposed to an 
animal suspected to be rabid, the compendium acknowl-
edges that although rabies is endemic in the United 
States, the incidence varies widely from one location to 
the next. Thus, without confirmatory testing, the risk 
that a dog bitten by a wild raccoon has truly been ex-
posed to rabies is much lower in, for example, Illinois 
than in Alabama. Nevertheless, given that the response 
to rabies booster vaccination in the present study was 
similar regardless of rabies vaccination status, we believe 
that postexposure management should be the same. 
In conclusion, results of the present study indicat-
ed that the anamnestic response to rabies booster vacci-
nation in dogs and cats with an out-of-date vaccination 
status is similar to the response for dogs and cat with a 
current vaccination status. Thus, we believe that post-
exposure management of any previously vaccinated 
dog or cat exposed to a confirmed or suspected rabid 
animal should be the same, regardless of vaccination 
status. Specifically, we believe that appropriate postex-
posure management for dogs and cats with an out-of-
date vaccination status is immediate booster vaccina-
tion followed by observation for 45 days, rather than 
euthanasia or quarantine for 6 months. If additional 
reassurance is needed, titers could be measured prior 
to and again 5 to 7 days after booster vaccination to de-
termine whether an anamnestic response has occurred.
a. Rainforth R, Merck, White House Station, NJ: Personal com-
munication, 2014.
b. Menardi R, Merial, Duluth, Ga: Personal communication, 2014.
c. Proc PHREG, SAS/STAT, version 9.3, SAS Institute Inc, Cary, NC.
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From this month’s AJVR 
Associations between early radiographic  
and computed tomographic measures  
and canine hip joint osteoarthritis at maturity
Anemone A. Andronescu et al
Objective—To evaluate associations of measures assessed by radiography, 2-D CT, and 3-D CT of 
the hip joints of immature dogs with osteoarthritis in the same joints at maturity.
Animals—46 hound-type dogs from a colony predisposed to osteoarthritis.
Procedures—Images of hip joints (1/dog) were obtained at 16, 32, and 104 weeks of age. Radio-
graphic measures included Norberg angle, distraction index, and osteoarthritis score. Two-dimensional 
CT measures included acetabular index; percentage of femoral head coverage; and center edge, hori-
zontal toit externe, acetabular anteversion, and ventral, dorsal, and horizontal acetabular sector angles. 
Three-dimensional CT measures were femoral head and neck volume, femoral neck angle, and femoral 
head and neck radius. Differences among measures at 16 and 32 weeks in dogs with different osteo-
arthritis scores at later time points, relationships among variables at each time point, and relationships 
of single and combined measures with the presence of osteoarthritis at 104 weeks were evaluated.
Results—The 16- and 32-week distraction index, center edge angle, dorsal acetabular sector angle, 
horizontal acetabular sector angle, percentage of femoral head coverage, acetabular index, and 
Norberg angle and the 32-week femoral neck angle varied significantly with osteoarthritis severity 
at 104 weeks. Presence of osteoarthritis in mature dogs was most strongly associated with 16-week 
combined measures of distraction index and center edge angle and 32-week combined measures of 
dorsal acetabular sector angle and Norberg angle.
Conclusions and Clinical Relevance—Changes in hip joint morphology associated with 
radiographic signs of osteoarthritis were detectable as early as 16 weeks of age and varied with 
osteoarthritis severity in adult dogs. The use of combined hip joint measures may improve early 
identification of dogs predisposed to hip joint osteoarthritis. (Am J Vet Res 2015;76:19–27)
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